G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 96 filers reported holding G1 THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,478 | -99.7% | 9,360 | -99.6% | 0.00% | -100.0% |
| Q2 2023 | $5,268,524 | -8.5% | 2,115,873 | -1.6% | 0.00% | 0.0% |
| Q1 2023 | $5,761,000 | +52021.6% | 2,149,526 | +5.6% | 0.00% | 0.0% |
| Q4 2022 | $11,053 | -100.0% | 2,035,622 | -0.4% | 0.00% | -75.0% |
| Q3 2022 | $25,527,000 | +142.7% | 2,043,773 | -4.0% | 0.00% | +300.0% |
| Q2 2022 | $10,520,000 | -34.0% | 2,129,449 | +1.5% | 0.00% | -50.0% |
| Q1 2022 | $15,943,000 | -27.2% | 2,097,753 | -2.1% | 0.00% | -33.3% |
| Q4 2021 | $21,887,000 | -27.2% | 2,143,684 | -4.3% | 0.00% | -25.0% |
| Q3 2021 | $30,058,000 | -27.0% | 2,239,679 | +19.4% | 0.00% | -20.0% |
| Q2 2021 | $41,162,000 | -6.4% | 1,876,160 | +2.6% | 0.01% | -16.7% |
| Q1 2021 | $43,980,000 | +46.5% | 1,827,889 | +9.6% | 0.01% | +50.0% |
| Q4 2020 | $30,015,000 | +51.3% | 1,668,422 | +0.3% | 0.00% | +33.3% |
| Q3 2020 | $19,837,000 | -60.0% | 1,664,181 | -18.7% | 0.00% | -70.0% |
| Q2 2020 | $49,628,000 | +165.5% | 2,045,708 | +20.6% | 0.01% | +150.0% |
| Q1 2020 | $18,689,000 | -57.6% | 1,695,819 | +1.6% | 0.00% | -50.0% |
| Q4 2019 | $44,115,000 | +55.5% | 1,669,139 | +34.0% | 0.01% | +33.3% |
| Q3 2019 | $28,365,000 | -36.2% | 1,245,185 | -12.9% | 0.01% | -33.3% |
| Q2 2019 | $44,446,000 | +139.4% | 1,429,138 | +27.8% | 0.01% | +125.0% |
| Q1 2019 | $18,568,000 | -5.8% | 1,118,524 | +8.7% | 0.00% | -20.0% |
| Q4 2018 | $19,707,000 | -29.0% | 1,029,074 | +93.8% | 0.01% | 0.0% |
| Q3 2018 | $27,765,000 | +40.3% | 530,979 | +16.6% | 0.01% | +25.0% |
| Q2 2018 | $19,787,000 | +141.0% | 455,289 | +105.5% | 0.00% | +100.0% |
| Q1 2018 | $8,209,000 | +2539.5% | 221,555 | +1313.5% | 0.00% | – |
| Q4 2017 | $311,000 | – | 15,674 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 994,287 | $19,041,000 | 1.55% |
| HHLR ADVISORS, LTD. | 949,431 | $18,182,000 | 0.75% |
| BB BIOTECH AG | 671,925 | $12,867,000 | 0.41% |
| Rhenman & Partners Asset Management AB | 172,820 | $3,310,000 | 0.38% |
| Birchview Capital, LP | 15,000 | $287,000 | 0.27% |
| Rock Springs Capital Management LP | 100,000 | $1,915,000 | 0.09% |
| SECOR Capital Advisors, LP | 32,591 | $624,000 | 0.08% |
| MARSHALL WACE, LLP | 386,510 | $7,402,000 | 0.08% |
| SIGNATUREFD, LLC | 37,942 | $727,000 | 0.07% |
| A.R.T. Advisors, LLC | 38,125 | $730,000 | 0.05% |